DeepMed Research

St. Jude Children's Research Hospital

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1962-01-01

Employees: -

Market Cap: -

Website: http://www.stjude.org/

Clinical Trials

Integration of mHEALTH Into the Care of Patients With Sickle Cell Disease to Increase Hydroxyurea Utilization

Not Applicable

Completed

Conditions: Sickle Cell Disease

Interventions: Behavioral: HU Toolbox mobile application
Behavioral: InCharge Health mobile application

First Posted Date: 2019-09-06

Last Posted Date: 2023-11-29

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 382

Registration Number: NCT04080167

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States
🇺🇸
Duke University, Durham, North Carolina, United States
🇺🇸
Georgia Regents University, Augusta, Georgia, United States

and more 4 locations

Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma

Not Applicable

Recruiting

Conditions: Pilocytic Astrocytoma
Diffuse Astrocytoma
Pleomorphic Xanthoastrocytoma
Ganglioglioma
Optic Pathway Glioma
Pilomyxoid Astrocytoma
Glioma

Interventions: Radiation: Hippocampal-avoidance proton therapy

First Posted Date: 2019-08-22

Last Posted Date: 2024-12-16

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 74

Registration Number: NCT04065776

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Patient-Reported Outcome Version of the Common Criteria for Adverse Events

Recruiting

Conditions: Survivorship
Cancer

Interventions: Other: Community non-cancer control
Other: SJLIFE
Other: Childhood Cancer Survivors (CCSS)

First Posted Date: 2019-08-08

Last Posted Date: 2025-05-08

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 765

Registration Number: NCT04050072

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescents With Refractory or Recurrent Group 3/Group 4 or SHH Medulloblastoma Brain Tumors

Phase 1

Completed

Conditions: Brain Tumor, Refractory
Brain Cancer
CNS Cancer
Brain Tumor
CNS Tumor
Medulloblastoma, Non-WNT/Non-SHH
CNS Neoplasm
Brain Tumor, Recurrent
Medulloblastoma
Medulloblastoma Recurrent

Interventions: Drug: Prexasertib
Drug: Cyclophosphamide
Drug: Gemcitabine
Biological: filgrastim
Biological: peg-filgrastim

First Posted Date: 2019-07-17

Last Posted Date: 2025-02-07

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 21

Registration Number: NCT04023669

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Neurostimulation In Adult Survivors of Childhood Acute Lymphoblastic Leukemia (ALL)

Not Applicable

Completed

Conditions: Acute Lymphoblastic Leukemia

Interventions: Device: Active tDCS
Device: Sham tDCS

First Posted Date: 2019-07-05

Last Posted Date: 2023-07-27

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 127

Registration Number: NCT04007601

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

T-cell Responses to Concurrent HIV and Herpesvirus Infections

Completed

Conditions: HIV
HIV Infections

Interventions: Other: T-cell lymphocyte responses

First Posted Date: 2019-06-24

Last Posted Date: 2024-11-15

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 135

Registration Number: NCT03996018

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia

Phase 2

Recruiting

Conditions: Acute Lymphoblastic Leukemia

Interventions: Drug: Inotuzumab ozogamicin
Drug: Methotrexate
Drug: Hydrocortisone
Drug: Cytarabine
Drug: Diphenhydramine
Drug: Acetaminophen
Drug: Methylprednisolone

First Posted Date: 2019-04-12

Last Posted Date: 2024-08-19

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 32

Registration Number: NCT03913559

Locations: 🇺🇸
Rady Children's Hospital San Diego, San Diego, California, United States
🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Trial of Antibody Responses by Vitamin Supplementation

Phase 1

Active, not recruiting

Conditions: Healthy Participants

Interventions: Biological: No vitamin A supplementation
Biological: Vitamin A supplementation

First Posted Date: 2019-03-01

Last Posted Date: 2025-04-03

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 22

Registration Number: NCT03859687

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies

Phase 2

Active, not recruiting

Conditions: Hodgkin Lymphoma
Acute Lymphoblastic Leukemia (ALL)
Acute Myeloid Leukemia (AML)
Myelodysplastic Syndromes (MDS)
NK-Cell Leukemia
Non Hodgkin Lymphoma (NHL)
Juvenile Myelomonocytic Leukemia (JMML)
Chronic Myeloid Leukemia (CML)

Interventions: Drug: Cyclophosphamide
Biological: Fludarabine
Drug: Thiotepa
Drug: Melphalan
Biological: G-csf
Drug: Mesna
Device: CliniMACS
Biological: ATG (rabbit)
Drug: Blinatumomab
Biological: TCRα/β+
Biological: CD19+
Biological: CD45RA-depleted DLI

First Posted Date: 2019-02-21

Last Posted Date: 2025-02-25

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 140

Registration Number: NCT03849651

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Feasibility and Agreement of Remote Evaluation of Resting Heart Rate and Heart Rate Variability in Survivors of Hodgkin Lymphoma Treated With Chest Radiation (PILOT STUDY-SURVIVOR)

Completed

Conditions: Hodgkin Disease

First Posted Date: 2019-02-12

Last Posted Date: 2024-08-09

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 34

Registration Number: NCT03838627

Locations: 🇺🇸
Kirsten Ness, Memphis, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy